Business Wire Feed
Greenfield Partners Unveils Workforce Housing Platform Domica
NAPLES, Fla.--(BUSINESS WIRE)--Greenfield Partners, a private real estate investment and development firm, today celebrated the launch of its essential employee housing platform, Domica. This bespoke housing solution is designed to serve employers – including those more...
As Enterprises Implement AI to Gain Productivity, Governance and Performance Measurement Present Scaling Opportunities: SS&C Survey
WINDSOR, Conn.--(BUSINESS WIRE)--As Enterprises Implement AI to Gain Productivity, Governance and Performance Measurement Present Scaling Opportunities: SS&C Survey
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment more...
Wisdom Panel Expands Dog DNA Test to Offer Largest Suite of Pet Behavioral Insights
FOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)-- #dogDNA--Now with over 25 behavioral insights, the world's leading pet DNA test delivers science-backed data to provide more ways to understand dogs.
BrightFocus Foundation’s $330+ Million Bet on High-Risk Science Pays Off, Independent Assessment Finds
CLARKSBURG, Md.--(BUSINESS WIRE)--For the last 53 years, BrightFocus Foundation, a nonprofit dedicated to Alzheimer’s, macular degeneration, and glaucoma research, has been making an unconventional bet. What happens when you give promising and emerging scientists funding more...
Maryland Tech Council Announces NIH Director, Former FDA Leaders, and Bad Blood Author to Headline Bio Innovation Conference
ROCKVILLE, Md.--(BUSINESS WIRE)--National Institutes of Health Director Jayanta “Jay” Bhattacharya, M.D., Ph.D., former Food & Drug Administration leaders Julie Tierney and Tala Fakhouri Ph.D. M.P.H., and investigative journalist and Bad Blood author John Carreyrou will more...
LTC Announces Date of Third Quarter 2026 Earnings Release, Conference Call and Webcast
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)---- $LTC #LTC--LTC Properties Inc. (NYSE: LTC) (“LTC” or the “Company”), a real estate investment trust that primarily invests in seniors housing and health care properties, today announced it will release third more...
Susan G. Komen®, Rep. Emilia Sykes and Northeast Ohio Advocates Discuss Barriers to Breast Cancer Diagnosis That Could Save Lives
CANTON, Ohio--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading nonprofit breast cancer organization, today joined Rep. Emilia Sykes, Northeast Ohio breast cancer advocates and Cleveland Clinic Mercy Hospital Cancer Center leaders for a community roundtable focused more...
Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the implementation and real-world experience with INTERCEPT Platelets and INTERCEPT Fibrinogen Complex, or IFC*, at the 2026 Association for more...
Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces CE marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers
Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal of Medicine (NEJM), providing more...
SOLVE FSHD Portfolio Company Altay Therapeutics Closes $37 Million Series A Financing to Advance DX5057 for FSHD
VANCOUVER, British Columbia--(BUSINESS WIRE)--SOLVE FSHD, a venture-philanthropy organization dedicated to accelerating therapies for facioscapulohumeral muscular dystrophy (FSHD), today celebrated the closing of a US$37 million Series A financing by portfolio company Altay Therapeutics, Inc. The more...
Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 2026
INCHEON, South Korea--(BUSINESS WIRE)-- #Celltrion--Celltrion will showcase its IBD portfolio, including Remsima™ SC, at UEG Week 2026 in Barcelona from Oct. 17 to 20.
Hôpital Montfort Establishes an Innovative Partnership to Accelerate Emergency Department Care
OTTAWA, Ontario--(BUSINESS WIRE)--Canadian digital platform for pre-triage, EmergConnect, was successfully evaluated through OBIO® in partnership with the Institut du Savoir Montfort.
Cogir Senior Living Partners With August Health to Power Clinical Operations Across More Than 120 Communities
SAN FRANCISCO--(BUSINESS WIRE)--August Health today announced a partnership with Cogir Senior Living, ranked ninth among U.S. senior living operators on the 2026 Argentum Largest Providers Report. Cogir will move all of its more than 120 more...
Access Medical Clinic Supports Families as New School Year Begins
FRANKLIN, Tenn.--(BUSINESS WIRE)--Rural healthcare provider Access Medical Clinic (AMC) is continuing its commitment to strengthening access to high-quality outpatient care while supporting the health and well-being of individuals and families in underserved communities. As part more...
MED Institute Joins Novelna’s ARPA-H Funded PULSE Consortium to Advance Wearable Biosensing
WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--MED Institute has joined Novelna Inc. and its consortium partners on Proactive Unified Longitudinal Sensing Ecosystem (PULSE), a wearable biosensing platform selected by the Advanced Research Projects Agency for Health (ARPA-H) under more...
JCR Pharmaceuticals Receives Marketing Authorization in Kuwait for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome
HYOGO, Japan--(BUSINESS WIRE)--JCR announced that IZCARGO, an enzyme replacement therapy indicated for Hunter syndrome, received marketing authorization in Kuwait.
Battelle, CMC Pharmaceuticals Advance Medical Countermeasure Program for U.S. Department of War
COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle and CMC Pharmaceuticals are advancing work with the United States Department of War to develop improved medical countermeasures intended to protect American warfighters from nerve agent threats. The five-year, $40 million Acetylcholinesterase more...
8 Bridge Group, LLC Announces Strategic Investment in 340BIntel, LLC; Expanding Its Healthcare Technology Portfolio
BIRMINGHAM, Ala.--(BUSINESS WIRE)--8 Bridge Group, LLC (“8 Bridge Group”) today announced its strategic investment and acquisition of a majority stake in 340BIntel, LLC (“340BIntel”), marking the firm’s expansion into the healthcare technology sector. The investment more...
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, will announce financial results for the quarter ended September 30, 2026 on Monday, October 26, 2026, more...
Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19- and CD22-targeted ARTEMIS® T-cell therapies to treat cancers and autoimmune diseases, today announced the activation of a more...
FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in combination with Bacillus more...
Behind the Knife and OpenEvidence Announce Collaboration to Bring Innovative Surgical Education to the Point of Care
MIAMI & SHAKER HEIGHTS, Ohio--(BUSINESS WIRE)-- #MedicalAI--Behind the Knife, the world's most listened-to surgery podcast and a leading nationwide source of surgical education, and OpenEvidence, the most popular AI for doctors in the United States, more...
LAFC Legend Carlos Vela and Saioa Cañibano Become Partners in Evoria Health
BEVERLY HILLS, Calif.--(BUSINESS WIRE)-- #CarlosVela--Carlos Vela and Saioa Cañibano join Evoria Health as partners, bringing a shared commitment to daily nutrition, longevity and recovery.